Clinical Trial Update: Comparative Clinical Study Evaluating the Possible Efficacy of Duloxetine, Gabapentin and Lacosamide on Oxaliplatin-Induced Peripheral Neuropathy in Cancer Patients [Phase 4]

View source ↗

Summary

Phase 4 study comparing duloxetine, gabapentin, and lacosamide for oxaliplatin-induced peripheral neuropathy in cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Neuropathy

Drugs mentioned

• Duloxetine (DULOXETINE)
• Gabapentin (Gabapentin)
• Lacosamide (Lacosamide)

Snippet

Sponsor: Tanta University | Conditions: Oncology | Phase 4 | Status: COMPLETED